Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to develope a one-step procedure to perform a biopsy of axillary lymph nodes on the same side as the breast tumor in women diagnosed with breast cancer.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Louisiana State University Health Sciences Center in New Orleans
• Treatments: Methylene Blue

Criteria

Inclusion Criteria:

• Stage 0,I, II breast cancer

• Clinical node status N0, N1

• No know allergy to iodine, lymphazurin or methylene blue dyes

Exclusion Criteria:

• Patient cannot be pregnant or nursing

• Prisoners will not be eligible

• Women under the age of 18 will not be eligible

• Patients with a known allergy to iodine or methylene blue or lymphazurin blue dyes